CD274 and non-small cell lung carcinoma: Also, the anti PDL-1 monoclonal antibody pembrolizumab has recently been adopted in the clinical practice of adjuvant strategies of resected NSCLC, after adjuvant chemotherapy or directly after surgery, as a unique treatment.